Mifepristone Maker Tells Supreme Court To Stop ‘Judicial Second-Guessing’ Of FDA
WASHINGTON, D.C. — The drug company that holds the new drug application (NDA) for the abortion drug mifepristone on April 19 urged the U.S. Supreme Court to stay a district court...To view the full article, register now.
Already a subscriber? Click here to view full article